We are a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with liver and other chronic diseases with high unmet medical need. We are evaluating seladelpar in primary biliary cholangitis (PBC). We also have a product program in earlier development that features a unique mechanism of action with potential in chronic diseases.
Company Profile
Industry Classifications
Sector:
Healthcare
Industry:
Biotechnology
NAICS:
Pharmaceutical Preparation Manufacturing (325412)
SIC:
Pharmaceutical Preparations (2834)
Contact Information
Investor Relations
LifeSci Advisors, LLC
Hans Vitzthum
T: (617) 430-7578
Hans@LifeSciAdvisors.com
Media
Evoke Kyne
Theresa Dolge
T: (609) 915-2156
Theresa.Dolge@evokegroup.com
Company Contact
CymaBay Therapeutics
7575 Gateway Blvd
Suite 110
Newark, CA 94560
T: (510) 293-8800
F: (510) 293-9090
info@cymabay.com